Skeletal Muscle · 2014 · 49 citations · 47 references
MedicinePathobiologyPathologyApoptosisInflammationMolecular PathologyCytokine-mediated PathologyExtracellular MatrixFibrosisFibrous ProteinsMuscle PathologyMuscular DystrophyExtracellular Matrix ProteinsFibrosis Following InflammationFibrosis PathogenesisFibrosis-associated CytokinesInflammatory Response GenesLaminin BiologyMuscular Dystrophy PathophysiologyNuclear Factor Kappa B Activation
BACKGROUND: MDC1A is a congenital neuromuscular disorder with developmentally complex and progressive pathologies that results from a deficiency in the protein laminin α2. MDC1A is associated with a multitude of pathologies, including increased apoptosis, inflammation and fibrosis. In order to assess and treat a complicated disease such as MDC1A, we must understand the natural history of the disease so that we can identify early disease drivers and pinpoint critical time periods for implementing potential therapies. RESULTS: We found that DyW mice show significantly impaired myogenesis and high levels of apoptosis as early as postnatal week 1. We also saw a surge of inflammatory response at the first week, marked by high levels of infiltrating macrophages, nuclear factor κB activation, osteopontin expression and overexpression of inflammatory cytokines. Fibrosis markers and related pathways were also observed to be elevated throughout early postnatal development in these mice, including periostin, collagen and fibronectin gene expression, as well as transforming growth factor β signaling. Interestingly, fibronectin was found to be the predominant fibrous protein of the extracellular matrix in early postnatal development. Lastly, we observed upregulation in various genes related to angiotensin signaling. METHODS: We sought out to examine the dysregulation of various pathways throughout early development (postnatal weeks 1-4) in the DyW mouse, the most commonly used mouse model of laminin-deficient muscular dystrophy. Muscle function tests (stand-ups and retractions) as well as gene (qRT-PCR) and protein levels (western blot, ELISA), histology (H&E, picrosirius red staining) and immunohistochemistry (fibronectin, TUNEL assay) were used to assess dysregulation of matricelluar protieins. CONCLUSIONS: Our results implicate the involvement of multiple signaling pathways in driving the earliest stages of pathology in DyW mice. As opposed to classical dystrophies, such as Duchenne muscular dystrophy, the dysregulation of various matricellular proteins appears to be a distinct feature of the early progression of DyW pathology. On the basis of our results, we believe that therapies that may reduce apoptosis and stabilize the homeostasis of extracellular matrix proteins may have increased efficacy if started at a very early age.
47
Keisuke Horiuchi, Norio Amizuka, Sunao Takeshita et al. · Journal of Bone and Mineral Research · 1999 · 996 citations · Full text
NF-κB-Induced Loss of <i>MyoD</i> Messenger RNA: Possible Role in Muscle Decay and Cachexia
Denis C. Guttridge, Marty W. Mayo, Lee V. Madrid et al. · Science · 2000 · 919 citations
Aberrant repair and fibrosis development in skeletal muscle
Christopher J. Mann, Eusebio Perdiguero, Yacine Kharraz et al. · Skeletal Muscle · 2011 · 845 citations · Full text